3.7.0.1 html 359 362 1 true 88 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bio-techne.com/20170630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Statements of Earnings and Comprehensive Income Sheet http://www.bio-techne.com/20170630/role/statement-consolidated-statements-of-earnings-and-comprehensive-income Consolidated Statements of Earnings and Comprehensive Income Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.bio-techne.com/20170630/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 3 false false R4.htm 003 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.bio-techne.com/20170630/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://www.bio-techne.com/20170630/role/statement-consolidated-statements-of-shareholders-equity Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.bio-techne.com/20170630/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Description of Business and Summary of Significant Accounting Policies Sheet http://www.bio-techne.com/20170630/role/statement-note-1-description-of-business-and-summary-of-significant-accounting-policies Note 1 - Description of Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Acquisitions Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions Note 2 - Acquisitions Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information Note 3 - Supplemental Balance Sheet and Cash Flow Information Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Fair Value Measurements Sheet http://www.bio-techne.com/20170630/role/statement-note-4-fair-value-measurements Note 4 - Fair Value Measurements Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Debt and Other Financing Arrangements Sheet http://www.bio-techne.com/20170630/role/statement-note-5-debt-and-other-financing-arrangements Note 5 - Debt and Other Financing Arrangements Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Commitments and Contingencies Sheet http://www.bio-techne.com/20170630/role/statement-note-6-commitments-and-contingencies- Note 6 - Commitments and Contingencies Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Accumulated Other Comprehensive Income Sheet http://www.bio-techne.com/20170630/role/statement-note-7-accumulated-other-comprehensive-income Note 7 - Accumulated Other Comprehensive Income Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Earnings Per Share Sheet http://www.bio-techne.com/20170630/role/statement-note-8-earnings-per-share Note 8 - Earnings Per Share Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Share-based Compensation and Other Benefit Plans Sheet http://www.bio-techne.com/20170630/role/statement-note-9-sharebased-compensation-and-other-benefit-plans- Note 9 - Share-based Compensation and Other Benefit Plans Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Income Taxes Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Segment Information Sheet http://www.bio-techne.com/20170630/role/statement-note-11-segment-information Note 11 - Segment Information Notes 17 false false R18.htm 017 - Document - Note 12 - Quarterly Financial Data (Unaudited) Sheet http://www.bio-techne.com/20170630/role/statement-note-12-quarterly-financial-data-unaudited Note 12 - Quarterly Financial Data (Unaudited) Uncategorized 18 false false R19.htm 018 - Disclosure - Note 13 - Subsequent Events Sheet http://www.bio-techne.com/20170630/role/statement-note-13-subsequent-events Note 13 - Subsequent Events Uncategorized 19 false false R20.htm 019 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.bio-techne.com/20170630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 2 - Acquisitions (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-tables Note 2 - Acquisitions (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-tables Note 3 - Supplemental Balance Sheet and Cash Flow Information (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 4 - Fair Value Measurements (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-4-fair-value-measurements-tables Note 4 - Fair Value Measurements (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 6 - Commitments and Contingencies (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-6-commitments-and-contingencies-tables Note 6 - Commitments and Contingencies (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 7 - Accumulated Other Comprehensive Income (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-7-accumulated-other-comprehensive-income-tables Note 7 - Accumulated Other Comprehensive Income (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 8 - Earnings Per Share (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-8-earnings-per-share-tables Note 8 - Earnings Per Share (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 9 - Share-based Compensation and Other Benefit Plans (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-9-sharebased-compensation-and-other-benefit-plans-tables Note 9 - Share-based Compensation and Other Benefit Plans (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 10 - Income Taxes (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes-tables Note 10 - Income Taxes (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 11 - Segment Information (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-11-segment-information-tables Note 11 - Segment Information (Tables) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 12 - Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.bio-techne.com/20170630/role/statement-note-12-quarterly-financial-data-unaudited-tables Note 12 - Quarterly Financial Data (Unaudited) (Tables) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 1 - Description of Business and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-1-description-of-business-and-summary-of-significant-accounting-policies-details-textual Note 1 - Description of Business and Summary of Significant Accounting Policies (Details Textual) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 2 - Acquisitions (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-details-textual Note 2 - Acquisitions (Details Textual) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 2 - Acquisitions - Summarized Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-summarized-fair-value-of-assets-and-liabilities-assumed-as-of-acquisition-date-details Note 2 - Acquisitions - Summarized Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 2 - Acquisitions - Pro Forma Financial Information (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-pro-forma-financial-information-details Note 2 - Acquisitions - Pro Forma Financial Information (Details) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 2 - Acquisitions - Final Fair Value of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-final-fair-value-of-assets-acquired-and-liabilities-assumed-details Note 2 - Acquisitions - Final Fair Value of Assets Acquired and Liabilities Assumed (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 2 - Acquisitions - Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-2-acquisitions-preliminary-estimated-fair-values-of-assets-acquired-and-liabilities-assumed-details Note 2 - Acquisitions - Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-details-textual Note 3 - Supplemental Balance Sheet and Cash Flow Information (Details Textual) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Inventories (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-inventories-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Inventories (Details) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Property and Equipment (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-property-and-equipment-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Property and Equipment (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Intangible Assets (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-intangible-assets-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Intangible Assets (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes to Carrying Amount of Net Intangible Assets (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-changes-to-carrying-amount-of-net-intangible-assets-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes to Carrying Amount of Net Intangible Assets (Details) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 3- Supplemental Balance Sheet and Cash Flow Information - Estimated Future Amortization Expense for Intangible Assets (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-estimated-future-amortization-expense-for-intangible-assets-details Note 3- Supplemental Balance Sheet and Cash Flow Information - Estimated Future Amortization Expense for Intangible Assets (Details) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-changes-in-carrying-amount-of-goodwill-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Other Assets (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-other-assets-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Other Assets (Details) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 3 - Supplemental Balance Sheet and Cash Flow Information - Supplemental Cash Flow Information (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-3-supplemental-balance-sheet-and-cash-flow-information-supplemental-cash-flow-information-details Note 3 - Supplemental Balance Sheet and Cash Flow Information - Supplemental Cash Flow Information (Details) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 4 - Fair Value Measurements (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-4-fair-value-measurements-details-textual Note 4 - Fair Value Measurements (Details Textual) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 4 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-4-fair-value-measurements-assets-and-liabilities-measured-on-a-recurring-basis-details Note 4 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 4 - Fair Value Measurements - Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-4-fair-value-measurements-liability-measured-at-fair-value-on-a-recurring-basis-using-significant-unobservable-inputs-details Note 4 - Fair Value Measurements - Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 5 - Debt and Other Financing Arrangements (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-5-debt-and-other-financing-arrangements-details-textual Note 5 - Debt and Other Financing Arrangements (Details Textual) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-6-commitments-and-contingencies-details-textual Note 6 - Commitments and Contingencies (Details Textual) Uncategorized 50 false false R51.htm 050 - Disclosure - Note 6 - Commitments and Contingencies - Aggregate Net Minimum Rental Commitments (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-6-commitments-and-contingencies-aggregate-net-minimum-rental-commitments-details Note 6 - Commitments and Contingencies - Aggregate Net Minimum Rental Commitments (Details) Uncategorized 51 false false R52.htm 051 - Disclosure - Note 7 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-7-accumulated-other-comprehensive-income-changes-in-accumulated-other-comprehensive-income-loss-net-of-tax-details Note 7 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) Uncategorized 52 false false R53.htm 052 - Disclosure - Note 8 - Earnings Per Share (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-8-earnings-per-share-details-textual Note 8 - Earnings Per Share (Details Textual) Uncategorized 53 false false R54.htm 053 - Disclosure - Note 8 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-8-earnings-per-share-shares-used-in-the-earnings-per-share-computations-details Note 8 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) Uncategorized 54 false false R55.htm 054 - Disclosure - Note 9 - Share-based Compensation and Other Benefit Plans (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-9-sharebased-compensation-and-other-benefit-plans-details-textual Note 9 - Share-based Compensation and Other Benefit Plans (Details Textual) Uncategorized 55 false false R56.htm 055 - Disclosure - Note 9 - Share-based Compensation and Other Benefit Plans - Stock Option Activity (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-9-sharebased-compensation-and-other-benefit-plans-stock-option-activity-details Note 9 - Share-based Compensation and Other Benefit Plans - Stock Option Activity (Details) Uncategorized 56 false false R57.htm 056 - Disclosure - Note 9 - Share-based Compensation and Other Benefit Plan - Assumptions Used in Black-Scholes Option-Pricing Model (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-9-sharebased-compensation-and-other-benefit-plan-assumptions-used-in-blackscholes-optionpricing-model-details Note 9 - Share-based Compensation and Other Benefit Plan - Assumptions Used in Black-Scholes Option-Pricing Model (Details) Uncategorized 57 false false R58.htm 057 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Uncategorized 58 false false R59.htm 058 - Disclosure - Note 10 - Income Taxes - Components of Provision for Income Taxes (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes-components-of-provision-for-income-taxes-details Note 10 - Income Taxes - Components of Provision for Income Taxes (Details) Uncategorized 59 false false R60.htm 059 - Disclosure - Note 10 - Income Taxes - Reconciliation of Federal Tax Calculated at Statutory Rate (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes-reconciliation-of-federal-tax-calculated-at-statutory-rate-details Note 10 - Income Taxes - Reconciliation of Federal Tax Calculated at Statutory Rate (Details) Uncategorized 60 false false R61.htm 060 - Disclosure - Note 10 - Income Taxes - Temporary Differences Comprising Deferred Taxes on Consolidated Balance Sheets (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-10-income-taxes-temporary-differences-comprising-deferred-taxes-on-consolidated-balance-sheets-details Note 10 - Income Taxes - Temporary Differences Comprising Deferred Taxes on Consolidated Balance Sheets (Details) Uncategorized 61 false false R62.htm 061 - Disclosure - Note 11 - Segment Information (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-11-segment-information-details-textual Note 11 - Segment Information (Details Textual) Uncategorized 62 false false R63.htm 062 - Disclosure - Note 11 - Segment Information - Financial Information Relating to Reportable Segments (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-11-segment-information-financial-information-relating-to-reportable-segments-details Note 11 - Segment Information - Financial Information Relating to Reportable Segments (Details) Uncategorized 63 false false R64.htm 063 - Disclosure - Note 11 - Segment Information - Financial Information Relating to Geographic Areas (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-11-segment-information-financial-information-relating-to-geographic-areas-details Note 11 - Segment Information - Financial Information Relating to Geographic Areas (Details) Uncategorized 64 false false R65.htm 064 - Disclosure - Note 12 - Quarterly Financial Data (Unaudited) - Quarterly Financial Information (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-12-quarterly-financial-data-unaudited-quarterly-financial-information-details Note 12 - Quarterly Financial Data (Unaudited) - Quarterly Financial Information (Details) Uncategorized 65 false false R66.htm 065 - Disclosure - Note 12 - Quarterly Financial Data (Unaudited) - Error Correction (Details) Sheet http://www.bio-techne.com/20170630/role/statement-note-12-quarterly-financial-data-unaudited-error-correction-details Note 12 - Quarterly Financial Data (Unaudited) - Error Correction (Details) Uncategorized 66 false false R67.htm 066 - Disclosure - Note 13 - Subsequent Events (Details Textual) Sheet http://www.bio-techne.com/20170630/role/statement-note-13-subsequent-events-details-textual Note 13 - Subsequent Events (Details Textual) Uncategorized 67 false false All Reports Book All Reports tech-20170630.xml tech-20170630.xsd tech-20170630_cal.xml tech-20170630_def.xml tech-20170630_lab.xml tech-20170630_pre.xml true true